Cite

HARVARD Citation

    Ellis, A. et al. (2017). Safety and pharmacodynamics of intranasal GSK2245035, a TLR7 agonist for allergic rhinitis: A randomized trial. Clinical & experimental allergy. 47 (9), pp. 1193-1203. [Online]. 
  
Back to record